Kestra Investment Management’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.72M Sell
31,530
-7,059
-18% -$344K 0.03% 159
2026
Q1
$1.66M Buy
38,589
+9,936
+35% +$427K 0.03% 154
2025
Q4
$1.26M Buy
28,653
+982
+4% +$40.6K 0.03% 179
2025
Q3
$1.14M Buy
27,671
+2,878
+12% +$116K 0.03% 187
2025
Q2
$1.09M Buy
24,793
+4,638
+23% +$185K 0.03% 180
2025
Q1
$744K Buy
20,155
+18,996
+1,639% +$677K 0.02% 205
2024
Q4
$38.6K Buy
+1,159
New +$37.6K ﹤0.01% 590

Other funds holding EXEL

Kestra Investment Management's EXEL Position: Q2 2026 in Review

Kestra Investment Management reduced its Exelixis (EXEL) stake by 18% in Q2 2026, selling an estimated $344K and leaving 31,530 shares worth $1.72M. The position accounts for 0.03% of the portfolio, ranked #159.

Kestra Investment Management first reported a position in EXEL in Q4 2024 and has held it in 7 quarters since. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Kestra Investment Management held 31,530 shares of Exelixis worth $1.72M as of Q2 2026.
  • Kestra Investment Management sold 7,059 Exelixis shares in Q2 2026, an estimated $344K.
  • Exelixis made up 0.03% of Kestra Investment Management's portfolio in Q2 2026, its #159 holding.
  • Kestra Investment Management first reported a position in Exelixis in Q4 2024 and has held it in 7 quarters since.
  • 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Kestra Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.